The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).
 
William A. Hall
Consulting or Advisory Role - Aktis Oncology
Research Funding - Elekta (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for a wearable device for radiation treatment planning (Inst)
Travel, Accommodations, Expenses - Elekta (Inst)
 
Theodore Karrison
No Relationships to Disclose
 
Bradley Alexander McGregor
Consulting or Advisory Role - Arcus Biosciences; Astellas Pharma; Bristol-Myers Squibb; Eisai; Exelixis; Gilead Sciences; Loxo/Lilly; Pfizer; Seattle Genetics/Astellas
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Pfizer/EMD Serono (Inst); Seattle Genetics/Astellas (Inst)
 
Pedro C. Barata
Honoraria - UroToday
Consulting or Advisory Role - AstraZeneca; AVEO; Bayer; BMS; Caris Life Sciences; Dendreon (Inst); Eisai; EMD Serono; Exelixis; Ipson; Merck; Pfizer
Speakers' Bureau - AstraZeneca; Bayer (Inst); Caris Life Sciences (Inst); Merck; Pfizer/Astellas (Inst)
Research Funding - AVEO (Inst); Blue Earth Diagnostics (Inst); Exelixis; Merck (Inst); Pfizer (Inst)
 
Himanshu Nagar
No Relationships to Disclose
 
Chad Tang
No Relationships to Disclose
 
shankar siva
Honoraria - AstraZeneca (Inst); Bayer (Inst); Bristol Meyer Squibb (Inst)
Research Funding - Bayer (Inst); Varian Medical Systems (Inst)
 
Todd Matthew Morgan
Consulting or Advisory Role - Foundation Medicine; Stratify Genomics; Tempus
Research Funding - MDxHealth (Inst)
 
Joshua Michael Lang
Stock and Other Ownership Interests - Salus Discovery
Consulting or Advisory Role - 4D Pharma; 4D Pharma; Arvinas; AstraZeneca; Gilead Sciences; Immunomedics; Janssen; Pfizer/Astellas; Pfizer/Myovant; Sanofi
Research Funding - Agensys (Inst); Arvinas (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Medivation (Inst)
Patents, Royalties, Other Intellectual Property - I am listed on the patent on a technology for rare cell capture and analysis. This technology has been licensed by Salus Discovery, LLC though no commercial products are available.
 
Carri Glide-Hurst
Research Funding - GE Healthcare
Patents, Royalties, Other Intellectual Property - US10201324B2 Patient interface system, method, and apparatus for categorizing whole-breast density from acoustic signal
Travel, Accommodations, Expenses - Varian Medical Systems
Other Relationship - Modus QA Medical Devices
 
Sophia C. Kamran
Employment - Sanofi (I)
Honoraria - Medscape; Varian Medical Systems
 
Karthik Sundaram
No Relationships to Disclose
 
Sharyn I. Katz
Consulting or Advisory Role - Trizell
Research Funding - Novartis
 
Felix Y Feng
No Relationships to Disclose
 
Rana R. McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)